Tag: BioNTech

The German biotechnology firm BioNTech is generating significant attention with compelling new clinical trial results for an investigational cancer vaccine. ...

The biotechnology sector is currently weathering a severe sell-off, and BioNTech SE finds itself at the center of the storm. ...

BioNTech SE finds its equity caught in a significant downdraft, pressured not by its fundamentals but by emerging political risks ...

A bombshell report from the Washington Post triggered a dramatic selloff in BioNTech shares this week, wiping out gains from ...

Shares of German biotechnology firm BioNTech faced renewed pressure on Friday following a media report examining potential COVID-19 vaccine side ...

Despite announcing a series of significant clinical breakthroughs and maintaining a robust financial position, BioNTech SE shares experienced notable downward ...

The landscape for mRNA therapeutics has transformed dramatically since the pandemic era. Two German pioneers in this revolutionary field now ...

Mainz-based biotechnology firm BioNTech, once celebrated as a pandemic-era vaccine champion, is executing a strategic pivot with billion-dollar implications. As ...

BioNTech has achieved a critical milestone in its oncology program, marking a significant advancement beyond its COVID-19 vaccine business. The ...

BioNTech SE has achieved a significant milestone in its oncology pipeline, sending its stock price sharply higher. The Mainz-based biotechnology ...